本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Adverum Biotechnologies, Inc.

2.93
-0.0500-1.68%
盘后2.930.00000.00%16:05 EDT
成交量:30.76万
成交额:88.50万
市值:6,120.93万
市盈率:-0.44
高:3.01
开:3.01
低:2.75
收:2.98
数据加载中...
2025/04/15

重要事件披露

Form 8-K - Current report
2025/04/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/31

重要事件披露

Form 8-K - Current report
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/12/19

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/18

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

重要事件披露

Form 8-K - Current report
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/07/22

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/17

重要事件披露

Form 8-K - Current report
2024/06/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/18

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report
2024/05/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]